AACR-ACS Award for Excellence in Cancer Epidemiology, Prevention honors Dr. Curtis Harris

February 28, 2014

SAN DIEGO -- The American Association for Cancer Research (AACR) and the American Cancer Society will recognize Curtis C. Harris, M.D., with the 23rd Annual AACR-American Cancer Society Award for Excellence in Cancer Epidemiology and Prevention at the AACR Annual Meeting 2014, to be held in San Diego, Calif., April 5-9.

Harris is head of the molecular genetics and carcinogenesis section of the Center for Cancer Research at the National Cancer Institute (NCI) in Bethesda, Md. He will present his lecture, "Integration of Molecular Epidemiology and Biomarkers in Precision Cancer Medicine," Tuesday, April 8, 3 p.m. PT, in Ballroom 20 A-C in the San Diego Convention Center.

The AACR-American Cancer Society Award for Research Excellence in Cancer Epidemiology and Prevention was established in 1992 to honor outstanding research accomplishments in the fields of cancer epidemiology, biomarkers, and prevention.

Harris is being recognized for his landmark scientific contributions to the fields of integrative and molecular epidemiology of human cancer and cancer biomarkers. He is particularly renowned for his pioneering studies of gene-environment interactions. For example, his laboratory was one of the first to document the link between the environmental carcinogen aflatoxin B1 and a specific mutation in the TP53 tumor suppressor gene in patients with hepatocellular carcinoma from Qidong, China. They also discovered that secondhand smoke exposure during childhood is associated with increased lung cancer risk among never smokers, particularly those carrying a certain genetic variation in their MBL2 gene. His research on environmental carcinogenesis, cancer risk factors, and the molecular genetics of human carcinogenesis, has significantly impacted the field of cancer risk assessment and our understanding of the molecular pathogenesis of human cancer.

"The support that AACR and ACS provide to advance NCI's mission of scientific research and discovery has been wonderful. On the behalf of my postdoctoral fellows and our national and international collaborators, I am honored to receive this award," Curtis said.

An active AACR member, Harris is a member of the Cancer Prevention Research editorial board and has served as an associate editor of Cancer Research and Cancer Epidemiology, Biomarkers & Prevention. He has also served on the AACR Board of Directors and on several committees, including as chair of the Princess Takamatsu Memorial Lectureship Selection Committee, an award he received in 2009.

Harris' accolades include the Distinguished Service Medal, which is the highest honor of the U.S. Public Health Service, the Alton Ochsner Award relating to smoking and health from the American College of Physicians, two outstanding mentor awards from the NCI, and an honorary doctorate from Nippon University School of Medicine in Tokyo, Japan. He is the editor-in-chief of the journal Carcinogenesis.

Harris received his medical degree from Kansas University School of Medicine in Kansas City, and completed his clinical training in internal medicine at the University of California, Los Angeles, and the NCI.
Press registration for the AACR Annual Meeting 2014 is free to qualified journalists and public information officers: http://www.aacr.org/AM14pressreg.

Follow the AACR Annual Meeting 2014 on Twitter: #AACR14

About the American Association for Cancer Research

Founded in 1907, the American Association for Cancer Research (AACR) is the world's oldest and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR membership includes more than 34,000 laboratory, translational, and clinical researchers; population scientists; other health care professionals; and cancer advocates residing in more than 90 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, biology, diagnosis, and treatment of cancer by annually convening more than 20 conferences and educational workshops, the largest of which is the AACR Annual Meeting with more than 18,000 attendees. In addition, the AACR publishes eight peer-reviewed scientific journals and a magazine for cancer survivors, patients, and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the Scientific Partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration, and scientific oversight of team science and individual grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and policymakers about the value of cancer research and related biomedical science in saving lives from cancer. For more information about the AACR, visit http://www.AACR.org. Follow the AACR Twitter: @AACR. Follow the AACR on Facebook: http://www.facebook.com/aacr.org.

American Association for Cancer Research

Related Biomarkers Articles from Brightsurf:

Urgent need for blood-based biomarkers to diagnosis concussion
There is an urgent need for objective markers for diagnosing concussion, or mild traumatic brain injury.

Engineered bacteria churn out cancer biomarkers
A Cornell lab has created these very tools by commandeering simple, single-celled microorganisms - namely E. coli bacteria - and engineering them to explore the complex process of glycosylation and the functional role that protein-linked glycans play in health and disease.

Exercise induces secretion of biomarkers into sweat
The aim was to reveal the potential of microRNAs in sweat extracellular vesicles in monitoring exercise performance.

Phosphoprotein biomarkers to guide cancer therapy are identified
Researchers led by James Bibb, Ph.D., professor of surgery at the University of Alabama at Birmingham, suggest using a broader lens of post-translational modification analysis to identify new biomarkers of cancer drivers that may allow a much more precise prediction of patient responses to treatments.

Exhaled biomarkers can reveal lung disease
Using specialized nanoparticles, MIT engineers have developed a way to diagnose pneumonia or other lung diseases by analyzing the breath exhaled by the patient.

Race-specific lupus nephritis biomarkers
A University of Houston biomedical researcher has discovered a difference in urinary biomarker proteins of lupus nephritis in patients according to race.

Semen miRNAs could be non-invasive biomarkers for prostate cancer
Researchers of the Human Molecular Genetics group at the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr.

Scientists have found longevity biomarkers
An international group of scientists studied the effects of 17 different lifespan-extending interventions on gene activity in mice and discovered genetic biomarkers of longevity.

After concussion, biomarkers in the blood may help predict recovery time
A study of high school and college football players suggests that biomarkers in the blood may have potential use in identifying which players are more likely to need a longer recovery time after concussion, according to a study published in the July 3, 2019, online issue of Neurology, the medical journal of the American Academy of Neurology.

3D-printed device detects biomarkers of preterm birth
Preterm birth (PTB) -- defined as birth before the 37th week of gestation -- is the leading complication of pregnancy.

Read More: Biomarkers News and Biomarkers Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.